EG 427
Developing gene therapy treatments
- B2B
About EG 427
Innovative biotech company using HSV-1 vector platform for targeted gene therapy in peripheral nervous system disorders, with focus on neurogenic bladder dysfunction
Key facts
- Industry
- Biotechnology Research
- Company size
- 11–50 employees
- Headquarters
- Paris, Île-de-France, France
- Founded
- 2019
- Revenue
- $5.8M – $45.9MTamtam estimate
- linkedin.com/company/eg427
EG 427 at a glance
EG 427 is a B2B company in the Biotechnology Research industry, headquartered in Paris, Île-de-France, France.
EG 427 was founded in 2019.
EG 427 has 11–50 employees.
EG 427's revenue is $5.8M – $45.9M (Tamtam estimate).
Selling to companies like EG 427?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies